Testosterone deficiency and quality of life in A ustralasian testicular cancer survivors: a prospective cohort study

This is the first prospective study in a contemporary A ustralian/ N ew Z ealand population to determine the prevalence of testosterone deficiency in testicular cancer survivors at 12 months from treatment, and any association with poorer quality of life. Hormone assays from 54 evaluable patients in...

Full description

Saved in:
Bibliographic Details
Published in:Internal medicine journal 2014-08, Vol.44 (8), p.813-817
Main Authors: O'Carrigan, B., Fournier, M., Olver, I. N., Stockler, M. R., Whitford, H., Toner, G. C., Thomson, D. B., Davis, I. D., Hanning, F., Singhal, N., Underhill, C., Clingan, P., McDonald, A., Boland, A., Grimison, P.
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This is the first prospective study in a contemporary A ustralian/ N ew Z ealand population to determine the prevalence of testosterone deficiency in testicular cancer survivors at 12 months from treatment, and any association with poorer quality of life. Hormone assays from 54 evaluable patients in a prospective cohort study revealed biochemical hypogonadism in 18 patients (33%) and low‐normal testosterone in 13 patients (24%). We found no association between testosterone levels and quality of life (all P > 0.05). Hypogonadal patients should be considered for testosterone replacement to prevent long‐term morbidity.
ISSN:1444-0903
1445-5994
DOI:10.1111/imj.12500